Related Experiment Video

Updated: Aug 20, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
03:47

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

[European study of ambulatory management of heart failure by cardiologists]

María J Salvador1, Alain Sebaoun, Frank Sonntag

  • 1mjsalvador@idexeus.es

Revista Espanola De Cardiologia
|December 25, 2004
PubMed

Insights

This study of 1252 heart failure outpatients across three countries found significant differences in causes like hypertension and ischemic heart disease. Beta-blocker use remains suboptimal despite increased ACE inhibitor prescription.

Area of Science:

  • Cardiology and Internal Medicine
  • Epidemiology of Chronic Diseases

Context:

  • Heart failure (HF) represents a significant global health burden, necessitating understanding of its clinical characteristics and management.
  • Outpatient cardiology settings are crucial for managing chronic conditions like HF.
  • Cross-cultural comparisons in healthcare practices can reveal disparities and areas for improvement.

Purpose:

  • To examine the clinical characteristics and management strategies for 1252 outpatients diagnosed with heart failure.
  • To compare the reported etiologies and treatment patterns of heart failure across Spain, France, and Germany.
  • To assess the utilization of key medications, including diuretics, ACE inhibitors, and beta-blockers, in heart failure management.

Summary:

  • A cross-sectional study involving 465 cardiologists surveyed 1252 heart failure outpatients on a single day in April 2001.
  • Significant international variations were observed in the prevalence of hypertension and ischemic heart disease as causes of heart failure.
  • While ACE inhibitor use showed a slight increase, beta-blocker underutilization persisted, with 52.3% of patients not receiving this class of medication.

Impact:

  • Highlights the substantial utilization of medical resources for heart failure management.
  • Underscores the need for standardized heart failure treatment protocols, particularly regarding beta-blocker prescription, across different healthcare systems.
  • Provides valuable data for public health initiatives aimed at optimizing heart failure care and reducing healthcare costs.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...